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Trends
L1 retrotransposons can mobilize dur-
ing embryogenesis, and in the neuro-
nal lineage, causing somatic genome
mosaicism.
Genomic analysis of endogenous L1
mobilization in mouse pedigrees, and
L1 transgenic rodents, has revealed
that the early embryo, before germ cell
speciﬁcation, is the primary niche for
the accumulation of new, heritable L1
insertions.
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L1 Mosaicism in Mammals:
Extent, Effects, and Evolution
Geoffrey J. Faulkner1,2,* and Jose L. Garcia-Perez3,4
The retrotransposon LINE-1 (long interspersed element 1, L1) is a transposable
element that has extensively colonized the mammalian germline. L1 retrotrans-
position can also occur in somatic cells, causing genomicmosaicism, aswell as
in cancer. However, the extent of L1-driven mosaicism arising during ontogen-
esis is unclear. We discuss here recent experimental data which, at a minimum,
fully substantiate L1 mosaicism in early embryonic development and neural
cells, including post-mitotic neurons. We also consider the possible biological
impact of somatic L1 insertions in neurons, the existence of donor L1s that are
highly active (‘hot’) in speciﬁc spatiotemporal niches, and the evolutionary
selection of donor L1s driving neuronal mosaicism.Neuronal progenitor cells and post-
mitotic neurons accommodate engi-
neered L1 retrotransposition, but other
cell lineages support limited or no L1
activity in the physiological conditions
tested to date.
L1 retrotransposition clearly occurs in
the brain, based on data obtained from
engineered L1 reporter systems and
single-cell genomic analysis, but the
relevant techniques and estimated L1
mobilization rates vary considerably.
Donor L1s can be differentially active in
germline and somatic cells, potentially
inﬂuencing the evolutionary selection
of donor L1s that are highly active in
the brain.
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Barbara McClintock discovered Ac/Ds transposition as the genetic basis for maize kernel
variegation nearly 70 years ago [1,2]. In this remarkable work, McClintock simultaneously
identiﬁed mobile DNA and its transposition in somatic cells, hence explaining the observed
mosaic kernel phenotype. Various forms of somatic genome mosaicism have since been
described [3] in normal and disease contexts, in both developing and adult tissues, involving
DNA changes ranging from a single nucleotide to entire chromosomes, and in some cases
these are central to crucial biological processes [4]. The mobile DNA ﬁeld founded by McClin-
tock has gone on to identify numerous transposable element (TE) families, which are arguably
the preeminent feature of most eukaryotic genomes sequenced to date [5], and are a major
source of genetic diversity and regulatory innovation [6,7]. However, despite an ongoing
emphasis on mammalian genomics, and the instructive effects of somatic transposition on
plant biology revealed by McClintock and others, our understanding of TE mobilization in
mammalian somatic cells remains in its infancy. In this Review we focus on recent reports of
LINE-1 (L1) retrotransposition during murine and human embryogenesis and neurogenesis,
discuss the potential biological signiﬁcance of somatic L1 insertions, and consider how L1
mosaicism may be subject to evolutionary selection.
L1 Retrotransposons
Retrotransposition is a molecular ‘copy-and-paste’ process [324_TD$DIFF]during which an RNA template is
reverse transcribed and integrated into the host genome, hence duplicating the donor DNA
sequence from which the RNA was transcribed [8]. In humans, more than 500 000 L1 copies
occupy 17% of the genome [9]. An intact, full-length L1 is 6 kb in length and initiates
transcription from a canonical 50 sense promoter (Figure 1A). The L1 mRNA encodes two
proteins [325_TD$DIFF](ORF1p and ORF2p) that catalyze L1 retrotransposition in cis [10]. The reverse
transcriptase and endonuclease activities of ORF2p are indispensable to efﬁcient retrotrans-
position [11–13]. L1 also encodes an antisense peptide, ORF0, which may assist L1 mobility
[14]. Most new L1 copies are rendered immobile by 50 truncation or internal mutation, leaving
only 80–100 potentially mobile L1s per individual human genome [15,16]. Of these, fewer than
10 are expected to mobilize efﬁciently if tested in vitro, and are therefore described as ‘hot’ L1sTrends in Genetics, Month Year, Vol. xx, No. yy http://dx.doi.org/10.1016/j.tig.2017.07.004 1
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faulknergj@gmail.com (G.J. Faulkner).[15,17–19]. The vast majority of hot L1s belong to one subfamily (L1-Ta, for transcribed-active)
[15,17]. Although L1 is the only remaining mobile, autonomous human TE, the non-
autonomous retrotransposon families Alu (a short interspersed element, [326_TD$DIFF]or SINE) and SVA
(a composite element incorporating SINE-R, a variable number of GC-rich tandem repeats, Alu,
and a 50 hexamer) can be retrotransposed in trans by the L1 protein machinery, as can be other
polyadenylated mRNAs, generating processed pseudogenes [20–24]. In mice, 3000 L1
copies representing three subfamilies (TF, GF, A) remain retrotransposition-competent
(Figure 1B) as do multiple endogenous retroviruses (ERVs) and non-autonomous SINE families
[25–29]. As opposed to an estimate of 1 new L1 insertion per 100 human births [30], at least 1 in
8 mice harbor a new L1 insertion [31], despite the similar percentages of identiﬁable L1
sequences in the mouse (19% from 600 000 copies) and human genomes [9,32].
L1-mediated retrotransposition typically occurs via a mechanism called target-primed reverse
transcription (TPRT) [33] (Box 1 and Figure 1C). As a result of TPRT, new L1 insertions typically
incorporate (i) an L1 endonuclease motif, (ii) target-site duplications (TSDs), and (iii) a poly(A) tail
[34]. Owing to cis-preference [10], L1 insertions usually arise from a retrotransposition-com-
petent donor L1, which in some cases can be identiﬁed by L1 ﬂanking transductions [35–37] or
diagnostic internal mutations [38]. Crucially, the hallmarks of TPRT can be utilized to discrimi-
nate genuine L1 retrotransposition events from other genetic or molecular events involving L1
sequences [13,33,34,39–41]. A new L1 insertion can greatly impact on gene structure and
function through insertional mutagenesis of exons [38,42,43] and regulatory elements [44],
disruption of RNA polymerase II processivity [45], premature polyadenylation [46], provision of
alternative promoters [14,47–51] (Figure 1A), and various other functional consequences [5,6].
L1 insertions are, likely as a result of evolutionary selection, not randomly distributed on the
genome and are depleted from exons and introns [52]. This mutagenic potential also means
that the L1 50 promoter, if present in a new insertion, is heavily repressed by the host genome in
most spatiotemporal contexts [48,53–56] (Figure 1D). Even in situations where full-length L1
transcripts are detected, these are usually generated by a limited number of L1 copies [38,50].
As a result, the L1 50 promoter is a major battleground in what has often been described as an
‘arms race’ pitting the interests of L1 to replicate against the interest of the host genome to
mitigate deleterious L1 mutations [57,58]. Beyond transcriptional repression, the host genome
has developed multiple strategies to limit ongoing retrotransposition (reviewed in [59–62]).
Methods to Detect L1 Retrotransposition
Two core strategies are available to resolve the spatial and temporal extent of L1 retrotrans-
position: L1 reporter assays and high-throughput sequencing. In 1996, an L1 reporter assay
[13] was adapted from an existing but ingenious design [8,63], and human donor L1s wereBox 1. Target-Primed Reverse Transcription (TPRT)
This seminal mechanistic model was proposed by the [320_TD$DIFF]Eickbush laboratory [33], based on experimental data obtained
from the silk moth R2 LINE-like retrotransposon, which provided a tractable system because it preferentially inserts into
28S rDNA genes [33,137]. Brieﬂy, for murine and primate L1s, TPRT involves the transcription and translation of a full-
length, capped, and polyadenylated L1 mRNA [21,139] followed by the association in cis of the L1 mRNA, ORF1p, and
ORF2p to generate a cytoplasmic ribonucleoprotein particle (RNP) [10]. The L1 RNP can next access the nucleus [118],
where the endonuclease activity of ORF2p [11] cleaves one genomic DNA strand at a degenerate 50-TTTT/AA site [34]
and then the ORF2p reverse transcriptase [12] initiates reverse transcription from the exposed 30-hydroxyl group using
the accompanying L1 mRNA as a template, generating a new L1 copy primed from the cleavage site [40]. After this
process, the second DNA strand is also cleaved, presumably by the sameORF2p endonuclease activity, near to the ﬁrst
cleavage site which, after the nascent L1 insertion is resolved by DNA synthesis, usually leads to the formation of target-
site duplications (TSDs) ﬂanking the newly synthesized DNA. Retrotransposition can also occur through variations of the
fundamental TPRT model [140–142] including occasional trans mobilization of mutant L1 mRNAs that do not encode
intact ORFs [10,143]. The TPRT mechanism is likely to be conserved in all vertebrates because, for example, eel and
zebraﬁsh LINEs retrotranspose in human cells [144,145].
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Figure 1. Mammalian Retrotransposons. (A) Mobile human retrotransposon families. L1, long interspersed element 1; Alu, a family of short interspersed elements
(SINEs); SVA, a composite of SINE-R, variable number of tandem repeats (VNTR), Alu, and 50 hexamer sequences; polymerase (Pol) II and Pol III promoters are
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functional by retrotransposition. In this assay, neomycin-resistant foci function as a readout of
L1 retrotransposition efﬁciency (Figure 2A, left). Remarkably, frequent L1 retrotransposition
events carrying TPRT hallmarks were observed in human and mouse cells (Box 1) [13]. As an
alternative approach, an enhanced green ﬂuorescent protein (EGFP)-based cassette was
[327_TD$DIFF]developed, yielding an L1–EGFP construct where EGFP was made functional by retrotrans-
position (Figure 2A, right) [65]. This approach facilitated the use of ﬂuorescence-based
microscopy and ﬂow cytometry to measure L1 retrotransposition efﬁciency, including in
transgenic animals in vivo [66]. In all, these reporter L1s and their derivatives (e.g., [67]) have
underpinned numerous studies elucidating retrotransposon biology over the past two decades,
and remain commonly used and effective tools (reviewed in [68]).
Alongside engineered L1 systems, high-throughput sequencing has massively increased our
ability to characterize DNA variation in human populations [52] and cancer genomes [69]. L1
insertions are, in this regard, merely one type of DNA structural variant and can be studied en
masse, either as part of a whole-genome sequencing (WGS) approach or via targeted
sequencing of L1–genome junctions (Figure 2B). Both strategies require careful computational
analysis and experimental validation to conﬁrm true L1 insertions [39,61,70], and typically
leverage L1 polymorphism catalogs [71–73] to discriminate between known and unknown L1
insertions. The bioinformatic identiﬁcation of new L1 insertions from WGS data [52,74–76] is
advantageous in that it can reveal the 50 and 30 L1–genome junctions of an insertion, allowing
substantial characterization of TPRT hallmarks a priori. As a result, WGS analyses tend to report
fewer false positives and ﬂexibly encompass more variations of TPRT (e.g., 30 transductions
[35–37] and 50 inversions [42,77]) than can be discerned using targeted methods [30,69,78,79]
analyzing only one (usually the 30) L1–genome junction. Some targeted methods do however
attempt to analyze both L1–genome junctions simultaneously [50,80,81] and, importantly,
WGS remains far more expensive than targeted approaches. Both general strategies can be
applied to ‘bulk’ DNA extracted from tissue or pooled cells, and to DNA ampliﬁed from
individual cells [82,83]. High-throughput sequencing has greatly expanded our overall capacity
to study endogenous L1s in vivo, as opposed to the considerable caveats of introducing a
transgenic L1 into a new epigenetic landscape [53,56,66,84,85]. If, however, congruent
experimental data are obtained from an L1 reporter and high-throughput sequencing applied
to a common biological system, such as cultured stem cells [86,87], the conclusions are likely
to be robust.
Heritable and Somatic L1 Retrotransposition during Early Development
How has L1 colonized nearly one-ﬁfth of the human and mouse genomes? Heritable L1
insertions must, by deﬁnition, occur in a germ cell or an embryonic cell contributing to the
germ line. A landmark 1988 study reported L1 mutagenesis of the factor VIII gene of two
hemophilia patients [42]. These results established that heritable de novo L1 insertions are still
occurring in humans and that these mutations [328_TD$DIFF]can cause disease. Nonetheless, the develop-
mental origin of de novo L1 retrotransposition remained unclear [42]. Subsequent murine
studies reported full-length L1 mRNA and L1 ORF1p expression in blastocysts, male and
female germ cells, and, interestingly, in placental syncytiotrophoblast cells [88–91]. Differentialrepresented by solid and empty arrows, respectively. (B) As for (A), except detailing mouse L1, SINE B1, SINE B2, and IAP (intracisternal A particle) endogenous
retrovirus (ERV) families. (C) Mechanism of target-primed reverse transcription (TPRT). First- and second-strand cleavage positions are depicted by red and green
arrowheads, respectively. (D) Factors activating and repressing the human L1 CpG island-centric 50-UTR promoter. CpG dinucleotides, including those assayed by two
studies [53,54], are represented with vertical orange strokes. Validated transcription factor (TF) binding sites are represented by horizontal red lines
[55,56,130,149,150]. Activator and repressor TFs are represented above and below the diagram, respectively. Abbreviations: EN, endonuclease; ENV, envelope;
GAG, group-speciﬁc antigen; HDAC, histone deacetylase; IN, integrase; LTR, long terminal repeat; ORF, open reading frame; POL, polymerase; RH, RNase H; RT,
reverse transcriptase; TSD, target-site duplication; UTR, untranslated region
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Figure 2. Methods to Identify Engineered and Endogenous L1 Insertions. (A) Schematic of an L1 reporter system. Retrotransposition from an exogenous
construct carrying an L1 tagged with a spliced ﬂuorescent reporter (e.g., EGFP [65]) or antibiotic resistance (e.g., neomycin [13]) activates the cassette, enabling
downstream analysis of L1 retrotransposition efﬁciency. (B) Targeted sequencing approaches to map an endogenous L1 insertion. Genomic DNA can be enriched for
L1–genome junctions via sequence capture [80], PCR, or adaptor ligation [30,50,79], sequenced, and computationally analyzed to reveal the de novo L1 variant.
Abbreviations: EN, endonuclease; ORF, open reading frame; RT, reverse transcriptase; TSD, target-site duplicationL1 expression was observed during germ cell speciﬁcation; for example, L1 ORF1p was
detected in primordial spermatogonia, as well as in the leptotene and zygotene stages of
spermatogenesis, but not in mature spermatids [88,91]. Together with later L1 transgenic
mouse experiments [66,85,92–94], recovery of endogenous L1 insertions from human germ
cells [95] and studies of human X-linked disease-causing L1 mutations [42,96,97], these
reports strongly suggested that endogenous L1 mobilization could occur in germ cells and
the early embryo.
Of highest relevance here is a study [97] that reported an L1 mutation associated with
choroideremia, a rare recessive X-linked condition, in an affected male proband. Notably,
his mother was a somatic and germline mosaic for the L1 insertion. This example irrefutably
demonstrated that endogenous L1 retrotransposition can occur early in human embryogene-
sis. In addition, the de novo L1 insertion carried a 30 transduction, allowing the authors to trace a
full-length donor L1 and prove that it mobilized efﬁciently in vitro using the L1 reporter assay
[65,97]. As a corollary, human embryonic stem cells (hESCs) support strong full-length L1
mRNA and L1 ORF1p expression [49,86,87,98–100], as do human induced pluripotent stem
cells (hiPSCs) [87,100,101], human embryonic carcinoma cells [49,84], mouse embryonic stem
cells (mESCs) [102], and mouse induced pluripotent stem cells (miPSCs) [101]. Consistently,
the L1–EGFP reporters mobilize in hESCs, hiPSCs, and embryonic carcinoma (PA-1) cells
[329_TD$DIFF] 84,86,100], indicating that embryonic cells are likely to be a natural habitat for L1
retrotransposition.Trends in Genetics, Month Year, Vol. xx, No. yy 5
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lines, followed by PCR validation of candidate de novo insertions in multiple laboratories [87].
hiPSCs were reprogrammed from multiple parental cell types using a variety of approaches,
again in several different laboratories. Eleven de novo L1, Alu, and SVA insertions were PCR-
validated. These data conﬁrmed that L1 is activated by reprogramming [100,103], a process
known to involve wholesale epigenomic changes [104]. Interestingly, de novo L1 insertions
identiﬁed in hiPSCs appeared unusually likely to be full-length, as found previously for L1–EGFP
insertions in hiPSCs [100] but not in hESCs [86]. The characteristics of L1 activity may therefore
be different in hiPSCs and hESCs, although an as-yet unrealized catalog of endogenous L1
insertions in cultured hESCs would be necessary to test this possibility.
In comparing the rate of endogenous L1mobilization in hiPSCs versus hESCs, we strongly urge
consideration of how heterogeneous each cell population is. Methodological factors, such as
stem cell culture conditions, population bottlenecks in cultured cells, bioinformatic parameters,
and how candidate L1 insertions are validated, if at all, can drastically inﬂuence results [39]. For
example, a recent study [105] appliedWGS to nine hiPSC lines and did not identify any de novo
retrotransposon insertions, and far fewer mutations overall when compared to earlier studies
[106,107]. Another report found 7 possible de novo L1 insertions in two hiPSC lines using
targeted L1 sequencing, but could not PCR validate or fully characterize the genomic integra-
tion sites of these events [103]. A further study that analyzed three miPSC lines with medium
coverage (10–12  depth) WGS detected no de novo L1 insertions, and concluded that
retroelement stability is the rule in miPSCs [108]. Given the accumulated evidence for L1
expression and mobilization in pluripotent cells, including retrotransposition of a codon-opti-
mized L1 TF element reporter [109–111] in mESCs ([330_TD$DIFF]M. Garcia-Canadas et al., unpublished), the
lack of de novo L1 insertions in miPSCs is perhaps surprising. There are, however, fundamental
differences in how miPSCs and hiPSCs are generated and cultured, and in addition, distinct
retrotransposon families appear to be more active depending on which mouse strain is
analyzed [26,29,31]. Overall, we conclude that reprogramming offers L1 a dynamic but
consistent relaxation of repression, and that L1 also encounters relaxed host genome control
in pluripotent cells obtained directly from embryonicmaterial [60,101,102,112]. Embryogenesis
therefore provides a favorable niche for L1 retrotransposition [31].
With this in mind, WGS and targeted sequencing was recently applied to 85 mouse genomes
obtained from three multigenerational C57BL/6J mouse pedigrees [31]. The developmental
timing of new L1 insertions identiﬁed in progeny was then traced in parental mice, via PCR and
quantitative PCR (qPCR) targeting the 50 L1–genome junction of individual insertions. In total,
11 de novo insertions were identiﬁed, with all being full-length (1 monomer) and belonging to
the TF subfamily, indicating a rate of at least one new L1 insertion per 8 births. Most heritable L1
insertions arose in the early embryo before germ cell speciﬁcation or in early primordial germ
cells (PGCs). For L1 insertions traced to the early embryo and early PGCs, transmission to
multiple offspring was routinely observed, suggesting that more than one allele of a given event
may be produced in one generation as a result of DNA replication errors and poly(A) tail
shortening post-integration [113]. TE diversity within inbred strains is therefore common and
adds to inter-strain variation [26,29].
Importantly, this study also identiﬁedmajor depletion of the 30 L1–genome junction for the active
mouse L1 families in Illumina sequencing data [31], and this was attributed to obstruction by an
extensive G-quadruplex region [114,115]. To our knowledge, this issue was not identiﬁed by
previous genomic analyses of mouse L1 insertions using WGS [108,116], but is potentially
problematic for TE discovery and sensitivity calculations. For this reason, we consider the
abovementioned ﬁgure of 1/8 to be conservative [31]. Moreover, data obtained from transgenic
animals suggest that most engineered L1 retrotransposition events occur in the soma and are6 Trends in Genetics, Month Year, Vol. xx, No. yy
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endogenous L1 insertions occurring in the embryo and later during ontogenesis and lineage
speciﬁcation.
Do Mature Neurons Support L1 Retrotransposition?
Over the past decade the L1–EGFP reporter system, alongside other approaches, has been
used to elucidate engineered L1 mobilization in neural progenitors arising during fetal and adult
neurogenesis (Box 2), suggesting that the brain may be a L1 mosaicism hotspot [53,56,84].
However, it remains unclear whethermature neurons, or other cell lineages, also accommodate
L1 activity. Recently a human L1–EGFP reporter was introduced into hESC-derived neuronal
precursor cells (NPCs) and, as seen previously [53,56], efﬁcient retrotransposition was
observed [99]. The authors then exploited a hybrid L1 adenoviral vector [118] to transduce
NPCs with a modiﬁed L1–EGFP reporter, overcoming limitations associated with plasmid
transfection, and again found L1 retrotransposition. Finally, the authors differentiated NPCs for
31 days to force neuronal maturation, then introduced either the adenoviral or plasmid
L1–EGFP reporter along with 5-bromo-20-deoxyuridine (BrdU), a marker of cycling cells,
and found that EGFP+[322_TD$DIFF] neuronal cells were present that were not stained with an anti-BrdU
antibody. These results suggested that non-dividing neuronal cells can support extensive
engineered L1 mobilization [118]. The authors performed parallel experiments in isogenic
hematopoietic and mesenchymal stem cells and, compared to NPCs, observed very low
L1 expression and L1–EGFP activity. Through infection with the adenoviral L1–EGFP reporter,
and the use of qPCR to measure integrated EGFP copies, it was determined that the rate of
L1–EGFP insertions in mature neurons was at least as high as in NPCs. These conclusions
relied heavily on PCR and qPCR detection of the spliced EGFP cassette, and normalization to a
plasmid or adenovirus [53]. Taken together, this study and previous studies focused on L1 in
NPCs [53,56,99] lead us to conclude that engineered L1 activity, in the cell types and
physiological conditions tested thus far, is largely restricted to the neuronal lineage, including
post-mitotic neurons.
Extent of Endogenous L1 Mobilization in the Brain
Despite ongoing debate regarding the various types of mosaic DNA variation found in the brain
[70,81,119–121], an unequivocal consensus view based on genomic analysis of bulk brain
tissue [53,80], individual cells [41,81–83], and clonal cell lines derived from individual neurons
[116] has formed: endogenous L1 retrotransposition can occur in the neuronal lineage, in line
with foundational data obtained from engineered L1 reporter systems [53,55,56,99]. Estimates
of L1 mobilization rate have nonetheless varied widely in each of the relevant studies, which
have used various analytical approaches (Table 1). The earliest, and most approximate,
calculations of per cell somatic L1 insertion counts were based on a L1 copy-number variationBox 2. Engineered L1 Mobilization in Neural Progenitor Cells
A 2005 study [56] discovered in vivo L1–EGFPmobilization in transgenic mouse neurons, as well as in cultured rat NSCs
and NPCs, providing foundational evidence of an L1 mosaic mammalian brain. Among various key ﬁndings, the authors
elucidated that Sox2, a transcription factor required to maintain NSC identity [146], is a repressor of the L1 50-
untranslated region (UTR) that is downregulated to complete neuronal maturation, hence providing a scenario for L1
mobilization [56,147]. A signiﬁcant caveat of this work was that it depended on a human L1 tagged with EGFP that was
integrated into the foreign epigenetic landscape of another species. A [321_TD$DIFF]subsequent study [53] showed that the L1–EGFP
reporter mobilized in human NPCs derived from fetal brain and hESCs in vitro, and that the CpG island at the core of the
L1-Ta promoter [148] was partially demethylated in fetal brain compared to non-neural tissues, further explaining L1
activation during neurogenesis. Through an L1 qPCR-based CNV assay, they determined that more L1 copies are
found in brain tissues than non-brain tissues [53]. Interestingly, both studies observed that neural cells known to carry
retrotransposed L1–EGFP copies could be negative for EGFP expression [53,56]. An epigenetic mechanism for
transcriptional silencing of integrated L1–EGFP copies was discovered in a follow-up paper [84], suggesting that
the rates of in vitro and in vivo engineered L1 retrotransposition observed in earlier work were likely to be conservative.
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hippocampal tissue, setting what appear now to be the extreme values of 80 and 0.04,
respectively. In a 2012 methodological tour de force [82], multiple displacement ampliﬁcation
(MDA) was coupled to an earlier targeted 30 L1 genome-sequencing approach [30,78] to create
human-speciﬁc L1 (L1Hs) insertion proﬁling (L1-IP). Application of L1-IP to 300 individual
pyramidal neurons from cortex and caudate nucleus revealed a single somatic L1 insertion
that carried a 50 transduction and which could be PCR ampliﬁed and capillary sequenced in its
entirety (an ‘empty/ﬁlled’ assay, which we consider to be the highest validation standard).
Another four events were detected by L1-IP but could be PCR ampliﬁed only at their 30
L1–genome junctions. Subsequent WGS [83] applied to 16 of the MDA-ampliﬁed cortical
neurons analyzed by L1-IP, including the neuron where the archetypal neuronal L1 insertion
[82] was found, re-identiﬁed that event as well as another somatic L1 insertion ﬂanked by a 614Table 1. Summary of Endogenous L1 Mobilization Rates in Mammalian Neurons
Study Species Tissues Puriﬁed
neurons?
Ampliﬁcation
strategya
Core L1 analysis
methodb
Estimated
somatic L1
insertions per
neuron
PCR validation
detailsc
Notes Refs
Coufal et al.
(2009)
Human Hippocampus,
cerebellum
No None (bulk) L1 qPCR 80 N/A Rate normalized to
plasmid spike [319_TD$DIFF]-in
[53]
Baillie et al.
(2011)
Human Hippocampus,
caudate nucleus
No None (bulk) RC-seq 0.04 Junction-speciﬁc Very approximate
post hoc rate
estimate [39]
[80]
Evrony et al.
(2012)
Human Cortex, caudate
nucleus
Yes MDA L1-IP 0.04 Empty/ﬁlled Validated [164_TD$DIFF]one
somatic L1
insertion carrying
a 50 transduction
with empty/ﬁlled
PCR, and four
additional L1
insertions via
junction-speciﬁc
PCR
[82]
Evrony et al.
(2015)
Human Cortex Yes MDA WGS 0.32 Empty/ﬁlled Found somatic
L1 insertion
ﬂanked by a
30 transduction
[83]
Upton et al.
(2015)
Human Hippocampus,
cortex
Yes MALBAC RC-seq 13.7 Junction-speciﬁc Ampliﬁcation
method
unsuitable for
empty/ﬁlled
PCR validation
[81]
Hazen et al.
(2016)
Mouse Olfactory bulb Yes SCNT WGS 1.3 Junction-speciﬁc L1 insertion
sequences
and families
not provided
[116]
Erwin et al.
(2016)
Human Hippocampus,
cortex
Yes MDA SLAV-seq 0.58–1 Empty/ﬁlled Also identiﬁed
putative somatic
L1-associated
deletions
[41]
aMALBAC, multiple annealing and looping-based ampliﬁcation cycles; MDA, multiple displacement ampliﬁcation; SCNT, somatic cell nuclear transfer.
bL1-IP, L1Hs insertion proﬁling; RC-seq, retrotransposon capture sequencing; SLAV-seq, somatic L1-associated variant sequencing; WGS, whole-genome
sequencing.
cDeﬁnitions: empty/ﬁlled, PCR targeting the complete L1 insertion via ampliﬁcation using primers positioned on either ﬂank of the L1 insertion, followed by capillary
sequencing (the gold standard approach); junction-speciﬁc, PCR targeting a 50 or 30 L1–genome junction; N/A, not applicable.
8 Trends in Genetics, Month Year, Vol. xx, No. yy
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single-cell studies of hippocampal and cortical neurons, employing MDA followed by somatic
L1-associated variant sequencing (SLAV-seq) [41], and multiple annealing and looping-based
ampliﬁcation cycles (MALBAC) followed by RC-seq [81], also identiﬁed and PCR-validated
multiple somatic L1 variants. Hence, single-cell genomic analyses have consistently found
strong evidence for endogenous L1 mobilization in the neuronal lineage (Table 1).
As a discipline still in its infancy, single-cell genomic analysis can lead to conclusions heavily
inﬂuenced by technical considerations. For example, a major signature of somatic C > T
mutations reported by one analysis of MDA-ampliﬁed neurons [119] was suggested to be an
artifact by another study employing a different genome-wide ampliﬁcation approach [120]. In
these circumstances, cooperation and consensus building are essential and, fortunately, the
ﬁeld is moving in this direction [70]. Nonetheless, the discovery and characterization of somatic
L1 insertions found in a handful of cells, or even one cell, via single-cell genomics remains
technically challenging [39] because whole-genome ampliﬁcation and sequencing library
preparation can each generate molecular artifacts, or chimeras, that obscure real L1 insertions.
Sophisticated bioinformatic strategies tailored to the underlying single-cell genomic approach
are hence necessary to distinguish between signal and noise. For example, variant discovery
with the three targeted L1 sequencingmethods used thus far to analyze neuronal genomes has
ﬁltered candidate de novo L1 insertions primarily based on read-count (L1-IP), L1 integration-
site sequence features (single-cell RC-seq), or a combination of both read-count and sequence
features (SLAV-seq) [41,81,82]. If the analysis approach suitable to one technique is applied to
another (e.g., applying lessons learned from single-cell RC-seq to L1-IP [81], or the reciprocal
application of a read-count ﬁlter suitable for L1-IP to single-cell RC-seq data already ﬁltered
based on sequence features [121]), the resulting L1 mobilization rate estimate can be very
different, necessitating method standardization [39,70]. The common ground shared by all of
these techniques is their high false positive rates, a [331_TD$DIFF]consequent need for rigorous and time-
consuming PCR validation, and their assumption that heterozygous L1 variants in single-cell
genomic analysis are equivalent to somatic L1 variants [41,81,82]. This latter consideration is
central to the estimation of false negatives. In this regard, it should be noted that the poly(A) tails
(91 nt and 107 nt in length, on average) of the two somatic L1 insertions validated to date by the
empty/ﬁlled PCR assay and presenting clear TSDs [83] are signiﬁcantly longer and more
adenine-pure than those carried by the vast majority of heterozygous L1 insertions [17] as
a result of rapid intraindividual and intergenerational poly(A) tail shortening [83,113], and this
phenomenon is evenmore evident for older L1 insertions [113]. Illumina sequencing is known to
have issues with long homopolymer tracts [122] and it is unclear how very long poly(A)
sequences fare during whole-genome ampliﬁcation. Moreover, it is interesting that engineered
L1 insertions have been shown to accumulate mainly in post-mitotic neurons [99], whereas the
two somatic L1 insertions referred to above were each detected in multiple neurons [83]. These
considerations lead us to ask whether the false negative rate has been consistently under-
estimated when assessing the degree of L1 mosaicism in the brain with single-cell genomics,
while acknowledging that accurate false positive rate calculations are essential [81,121]. Finally,
it must be noted that single-cell genomic analyses of L1 mobilization have been performed on
very few human brain samples thus far, and on broad neuronal types, leaving open the
possibility that some individuals, brain regions, or neuronal subtypes may support more
endogenous L1 activity than others, and thus contribute to disparate somatic L1 retrotrans-
position frequency estimates.
To our knowledge, no single-cell analysis of endogenous L1mobilization in themouse brain has
been reported to date. However, in an elegant study, somatic cell nuclear transfer (SCNT) was
used to reprogram mESCs with neuronal nuclei obtained from the mouse olfactory bulb,
followed by clonal expansion and bulk WGS to identify de novo TE insertions and other somaticTrends in Genetics, Month Year, Vol. xx, No. yy 9
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ampliﬁcation and eliminated errors associated with the latter technique, although also poten-
tially selecting neuronal nuclei with a lower burden of DNA damage (including from L1) [116]. In
six reprogrammed neuronal clones, four de novo L1 insertions were validated through junction-
speciﬁc PCR and capillary sequencing, revealing in each case hallmark features of TPRT.
Based on a false negative rate of approximately 50%, the analyzed neurons likely each
contained 1.3 somatic L1 insertions, on average. Interestingly, this rate estimate differed
dramatically from the extrema values of 0.04 [82] and 13.7 [81] obtained from single-cell
genomic analysis of human neurons, although L1 appears to be more active in the mouse than
in the human germline [30,31]. It is unclear how much, if at all, the 30 L1–genome junction
depletion observed recently in WGS and RC-seq data [31] affected the false negative rate
calculation of this study, given that theWGS analysis appeared to group all TE families together
when calculating false negative rate, and the 30 depletion observed elsewhere was L1-speciﬁc
[31]. More generally, it is unknown howmuch L1 activity varies in the brains of different species,
or different inbred animal strains, or for that matter how much ageing and senescence impact
on TE mosaicism in species with very dissimilar lifespans [123–126]. It is nonetheless remark-
able that L1 mosaicism may be very common in the mouse brain, and conserved in Mammalia,
based on the conservative estimate that olfactory neurons contain at least one somatic L1
insertion, on average [116].
When Does L1 Jump in Brain Development?
As noted above, engineered L1 insertions occur throughout fetal and adult neurogenesis, as
well as in mature neurons [53,56,99]. With regards to endogenous L1 activity, one study
detected two somatic L1 insertions, each in 2/16 neurons assayed by WGS [83]. By lineage
tracing, the authors found that one of these events was timed to occur in the developing cortex
and the other likely arose early in central nervous system development, and perhaps even
earlier [83]. The latter circumstance reconciles well with embryonic events elucidated in mouse
[31,92]. By contrast, two other studies found that most of these events appeared to arise later in
neurogenesis [41,81], agreeing with reports of engineered L1 mobilization in post-mitotic
neurons [99]. Interestingly, studies of engineered and endogenous L1 retrotransposition in
brain tissues and neural cells have recurrently found L1 insertions in neuronal genes
[41,53,56,80,81] and enhancers active in neuronal stem cells (NSCs) [81], raising the prospect
of integration patterns speciﬁc to the neuronal epigenetic landscape, or post-integration
selection. Pyramidal and other neuronal subtypes have been shown to contain somatic L1
insertions [81–83], as have, in far fewer instances, glia [41,81]. It therefore remains unclear
whether most somatic L1 insertions found in the brain arose in the embryo, during neuro-
genesis, in mature post-mitotic neurons, or, as is possible, in each of these scenarios, leading
to complex neuronal mosaicism.
A Model for Evolutionary Selection of Somatic L1 Retrotransposition
Is an L1 mosaic brain functionally distinct from an L1 homogenous brain? We note here only
that (i) neuronal circuitry is highly interconnected and exquisitely sensitive to perturbation [127],
(ii) intragenic L1 insertions can grossly impact on gene function [42,45], (iii) despite this, the
potential roles of L1 mosaicism in learning and cognition remain almost entirely theoretical
[39,128,129], and (iv) abnormal somatic L1 activity in neurological disorders, including Rett
syndrome (RTT) [55,130], schizophrenia [131], and ataxia telangiectasia [132], has also been
considered extensively but, apart from RTT, the related etiological contribution of L1 to disease
is very unclear. Even for RTT, where MeCP2, a major L1 transcriptional repressor [130], is
mutated and L1 mRNA, L1 protein, and L1–EGFP transgene activity are all elevated [55],
MeCP2 conditional rescue can restore apparently normal neurobiological function in mice
[133], meaning that L1 mosaicism is unlikely to be a major component of RTT neuronal10 Trends in Genetics, Month Year, Vol. xx, No. yy
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[38,42,43], it remains wholly unclear whether this applies to normal or abnormal neurobiology.
Somatic mutations are, of course, not inherited. However, donor L1s causing de novo L1
insertions in somatic cells are carried through the germline, and are therefore subject to
selection because they can simultaneously cause germline and somatic mosaicism [31,38].
Moreover, if a particular donor L1 is very active in somatic cells it may affect the immediate
evolutionary ﬁtness of the carrier individual through disease [38,43] or even positive develop-
mental or neurological consequences, if they exist [129]. That some L1s are apparently more
mobile in somatic cells than elsewhere is supported by the identiﬁcation of donor L1s that are
far more active in tumors than would be expected by their activity in the germline, such as an
oft-transduced donor L1 in the TTC28 gene of numerous cancer genomes [76]. Reciprocally,
some donor L1s are sufﬁciently active to give rise to multiple donor L1 progeny in the human
germline, but have not been found to be particularly active in cancer [17,76,134]. Finally, some
donor L1s are highly active in both the germline and tumors [17,38].
Donor L1s can each have multiple alleles, which can in turn mobilize at very different rates, even
in the same context [18,19]. Moreover, the same donor L1maymobilize well in one context and
not another [50]. For example, the donor L1 found previously to generate a 30 transduction-
ﬂanked neuronal L1 insertion [83] putatively mobilized during brain development but, when
tested with an L1 reporter assay, did not retrotranspose in cultured osteosarcoma cells [15]. It
follows that, as more active donor L1s generate longer new L1 insertions [135], they have a
higher chance of generating retrotransposition-competent L1 insertions that can be easilyKey Figure
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Figure 3. Schematic representation of donor L1s and their distinct impacts on germline and somatic mosaicism in two individuals. Each donor L1 locus (numbered
from [164_TD$DIFF]one to 13) can be empty (black) or contain either a retrotransposition-competent (red color) or -incompetent (grey) L1. Donor L1s can be heterozygous or
homozygous. Locus-speciﬁc L1 activation can be restricted by tissue, developmental stage, or cell type (B, brain; Co, colon; E, embryo; Gl, germline; Lv, liver; O,
oncological processes), or can be unrestricted (asterisk). In the anatomic panels of the respective individuals, colors and numbers represent the potential contexts of
somatic L1 variants and their matched donor L1s
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Outstanding Questions
Human pluripotent stem cells obtained
via reprogramming or from embryonic
material consistently support L1 retro-
transposition, as do mouse embryonic
stem cells. However, it is unclear as to
why de novo L1 insertions apparently
do not occur in miPSCs. Is this a tech-
nical issue – or a result of mouse L1s
being less amenable to jumping during
reprogramming than human L1s
(despite seeming more active in the
early embryo)? Moreover, although
endogenous L1 retrotransposition is
now well demonstrated in the mouse
embryo, it is less well deﬁned in terms
of spatial extent and frequency in early
human embryogenesis.
What is the frequency of endogenous
L1 mobilization in the brain? It is
accepted that L1 can jump in the brain;
however, the available rate estimates,
and interpretations of the same data,
vary widely. A focus on false positives
should be complemented by a closer
examination of false negatives, and
standardization of techniques. L1
insertions are likely to occur in post-
mitotic neurons, meaning that even a
low rate of neuronal L1 mobilization
could generate a constellation of L1
variation among the 1011 neurons
in the human brain. [332_TD$DIFF] oes mosaicism
vary among different neuronal
subtypes?
What are the immediate and broader
functional consequences of somatic
L1 insertions in the brain? Transcrip-
tomic and genomic analysis of the
same individual neuron could, at least,
answer the ﬁrst question. The impact
of L1 mosaicism on neurobiology is a
much more challenging and large-
scale issue, with little clear evidence
produced to date of somatic L1 inser-
tions impacting on neurological func-
tion, psychiatric disorders, or
neurodegenerative diseases.traced back to their donor L1s by 50 or 30 transduced sequences, as was the case for both of
the neuronal L1 insertions referred to above [83]. For these reasons, we hypothesize that donor
L1s that are ‘hot’ for retrotransposition [15] in particular somatic contexts in vivo (Figure 3, Key
Figure) exist in the human population. This possibility is further supported by context-speciﬁc
donor L1 activity in cultured cell lines [50], and a recent colorectal cancer study [38] that found a
tumorigenic L1 insertion in the APC gene and traced that mutation to a polymorphic donor L1
that was demethylated not only in the tumor but also the matched normal colon [17]. If other
polymorphic donor L1s are highly active in the brain, and L1 mosaicism is ultimately found to
impact on neurobiology, we predict that donor L1s, the regulatory elements they carry (e.g.,
antisense promoters [14,48]), and the relevant host defense factors may undergo genetic
selection due to their activity in the soma. Despite somatic L1 insertions not being inherited, this
model could lead to varying rates of L1 mosaicism among individuals, and thus subject the
phenomenon to natural selection.
Concluding Remarks and Future Directions
Endogenous L1 retrotransposition occurs in the embryo and during neurogenesis, and causes
somatic genomemosaicism in neurons. The character of thismosaicism, in terms of complexity
and impact, remains largely undeﬁned. However, because the average human brain contains
80–100 billion neurons [136], even the most conservatives estimates of neuronal L1 mosaicism
extrapolate to a very extensive catalogue of L1-driven variation within any individual. We would
also expect that some neuronal subtypes support more L1 activity than others, perhaps as a
function of when during life those neurons arise, their spatial distribution in the brain, or their
neurobiological function, and in those neurons the potential for L1 insertions to drive phenotypic
diversity is arguably higher than in cells that carry few or no somatic L1 insertions. TE
mobilization in somatic cells is, of course, not restricted to mammals, with McClintock’s maize
[1,2], silk worm [137], and fruit ﬂy [125,138] each providing examples of mosaicism caused by
mobile DNA. Major advances in single-cell genomic analysis and high-throughput sequencing
therefore leave the ﬁeld well placed to further deﬁne somatic genome mosaicism, and its
potential functional consequences, in different species and biological contexts (see
Outstanding Questions).
Acknowledgments
G.J.F. acknowledges the support of a CSL Centenary Fellowship, National Health and Medical Research Council
(NHMRC) Project Grants (GNT1106206, GNT1125645, GNT1126393) and theMater Foundation. J.L.G-P. acknowledges
funding from CICE-FEDER-P12-CTS-2256, Plan Nacional de I+D+I 2013–2016 (FIS-FEDER-PI14/02152), PCIN-2014-
115-ERA-NET NEURON II, the European Research Council (ERC-Consolidator ERC-STG-2012-233764), an International
Early Career Scientist grant from the Howard Hughes Medical Institute (IECS-55007420), and The Wellcome
Trust–University of Edinburgh Institutional Strategic Support Fund (ISFF2). We thank Francisco Sanchez-Luque for helpful
discussions and ﬁgure design, and Sandra Richardson and Adam Ewing for critical review of the manuscript.
ReferencesIf, however, L1 mosaicism impacts on
neurobiology, it is plausible that donor
L1s highly active in the neuronal line-
age may undergo evolutionary selec-
tion despite their offspring somatic L1
insertions not being heritable. The
available experimental data suggest
that some donor L1s are unusually
active in cancer genomes. The same
may be true of donor L1s in normal
somatic cells, including neurons.
Hence, the donor L1 cohort of individ-
uals, and their haplotypes, may deﬁne1. McClintock, B. (1951) Chromosome organization and genic
expression. Cold Spring Harb. Symp. Quant. Biol. 16, 13–47
2. McClintock, B. (1950) The origin and behavior of mutable loci in
maize. Proc. Natl. Acad. Sci. U. S. A. 36, 344–355
3. Campbell, I.M. et al. (2015) Somatic mosaicism: implications
for disease and transmission genetics. Trends Genet. 31,
382–392
4. Hozumi, N. and Tonegawa, S. (1976) Evidence for somatic
rearrangement of immunoglobulin genes coding for variable
and constant regions. Proc. Natl. Acad. Sci. U. S. A. 73,
3628–3632
5. Levin, H.L. and Moran, J.V. (2011) Dynamic interactions
between transposable elements and their hosts. Nat. Rev.
Genet. 12, 615–627
6. Chuong, E.B. et al. (2017) Regulatory activities of transposable
elements: from conﬂicts to beneﬁts. Nat. Rev. Genet. 18, 71–8612 Trends in Genetics, Month Year, Vol. xx, No. yy7. Britten, R.J. and Davidson, E.H. (1969) Gene regulation for
higher cells: a theory. Science 165, 349–357
8. Boeke, J.D. et al. (1985) Ty elements transpose through an RNA
intermediate. Cell 40, 491–500
9. Lander, E.S. et al. (2001) Initial sequencing and analysis of the
human genome. Nature 409, 860–921
10. Wei, W. et al. (2001) Human L1 retrotransposition: cis prefer-
ence versus trans complementation. Mol. Cell. Biol. 21,
1429–1439
11. Feng, Q. et al. (1996) Human L1 retrotransposon encodes a
conserved endonuclease required for retrotransposition. Cell
87, 905–916
12. Mathias, S.L. et al. (1991) Reverse transcriptase encoded by a
human transposable element. Science 254, 1808–1810
13. Moran, J.V. et al. (1996) High frequency retrotransposition in
cultured mammalian cells. Cell 87, 917–927
TIGS 1381 No. of Pages 15
the level of L1 activity in the embryo
and brain.14. Denli, A.M. et al. (2015) Primate-speciﬁc ORF0 contributes to
retrotransposon-mediated diversity. Cell 163, 583–593
15. Brouha, B. et al. (2003) Hot L1s account for the bulk of
retrotransposition in the human population. Proc. Natl. Acad.
Sci. U. S. A. 100, 5280–5285
16. Mills, R.E. et al. (2007) Which transposable elements are active
in the human genome? Trends Genet. 23, 183–191
17. Beck, C.R. et al. (2010) LINE-1 retrotransposition activity in
human genomes. Cell 141, 1159–1170
18. Lutz, S.M. et al. (2003) Allelic heterogeneity in LINE-1
retrotransposition activity. Am. J. Hum. Genet. 73, 1431–1437
19. Seleme, M.C. et al. (2006) Extensive individual variation in L1
retrotransposition capability contributes to human genetic
diversity. Proc. Natl. Acad. Sci. U. S. A. 103, 6611–6616
20. Esnault, C. et al. (2000) Human LINE retrotransposons generate
processed pseudogenes. Nat. Genet. 24, 363–367
21. Doucet, A.J. et al. (2015) A 30 poly(A) tract is required for LINE-1
retrotransposition. Mol. Cell 60, 728–741
22. Hancks, D.C. et al. (2011) Retrotransposition of marked SVA
elements by human L1s in cultured cells. Hum. Mol. Genet. 20,
3386–3400
23. Dewannieux, M. et al. (2003) LINE-mediated retrotransposition
of marked Alu sequences. Nat. Genet. 35, 41–48
24. Ahl, V. et al. (2015) Retrotransposition and crystal structure of an
Alu RNP in the ribosome-stalling conformation. Mol. Cell 60,
715–727
25. Ostertag, E.M. and Kazazian, H.H., Jr (2001) Biology of
mammalian L1 retrotransposons. Annu. Rev. Genet. 35,
501–538
26. Nellaker, C. et al. (2012) The genomic landscape shaped by
selection on transposable elements across 18 mouse strains.
Genome Biol. 13, R45
27. Sookdeo, A. et al. (2013) Revisiting the evolution of mouse
LINE-1 in the genomic era. Mob DNA 4, 3
28. Goodier, J.L. et al. (2001) A novel active L1 retrotransposon
subfamily in the mouse. Genome Res. 11, 1677–1685
29. Maksakova, I.A. et al. (2006) Retroviral elements and their hosts:
insertional mutagenesis in the mouse germ line. PLoS Genet. 2,
e2
30. Ewing, A.D. and Kazazian, H.H., Jr (2010) High-throughput
sequencing reveals extensive variation in human-speciﬁc L1
content in individual human genomes. Genome Res. 20,
1262–1270
31. Richardson, S.R. et al. (2017) Heritable L1 retrotransposition in
the mouse primordial germline and early embryo. Genome Res.
Published online May 8, 2017. http://dx.doi.org/10.1101/
gr.219022.116
32. Waterston, R.H. et al. (2002) Initial sequencing and comparative
analysis of the mouse genome. Nature 420, 520–562
33. Luan, D.D. et al. (1993) Reverse transcription of R2Bm RNA is
primed by a nick at the chromosomal target site: a mechanism
for non-LTR retrotransposition. Cell 72, 595–605
34. Jurka, J. (1997) Sequence patterns indicate an enzymatic
involvement in integration of mammalian retroposons. Proc.
Natl. Acad. Sci. U. S. A. 94, 1872–1877
35. Goodier, J.L. et al. (2000) Transduction of 30-ﬂanking sequences
is common in L1 retrotransposition. Hum. Mol. Genet. 9,
653–657
36. Moran, J.V. et al. (1999) Exon shufﬂing by L1 retrotransposition.
Science 283, 1530–1534
37. Pickeral, O.K. et al. (2000) Frequent human genomic DNA
transduction driven by LINE-1 retrotransposition. Genome
Res. 10, 411–415
38. Scott, E.C. et al. (2016) A hot L1 retrotransposon evades
somatic repression and initiates human colorectal cancer.
Genome Res. 26, 745–755
39. Richardson, S.R. et al. (2014) L1 retrotransposons and somatic
mosaicism in the brain. Annu. Rev. Genet. 48, 1–27
40. Monot, C. et al. (2013) The speciﬁcity and ﬂexibility of L1 reverse
transcription priming at imperfect T-tracts. PLoS Genet. 9,
e100349941. Erwin, J.A. et al. (2016) L1-associated genomic regions are
deleted in somatic cells of the healthy human brain. Nat.
Neurosci. 19, 1583–1591
42. Kazazian, H.H., Jr et al. (1988) Haemophilia A resulting from de
novo insertion of L1 sequences represents a novel mechanism
for mutation in man. Nature 332, 164–166
43. Miki, Y. et al. (1992) Disruption of the APC gene by a
retrotransposal insertion of L1 sequence in a colon cancer.
Cancer Res. 52, 643–645
44. Shukla, R. et al. (2013) Endogenous retrotransposition activates
oncogenic pathways in hepatocellular carcinoma. Cell 153,
101–111
45. Han, J.S. et al. (2004) Transcriptional disruption by the L1
retrotransposon and implications for mammalian transcrip-
tomes. Nature 429, 268–274
46. Perepelitsa-Belancio, V. and Deininger, P. (2003) RNA
truncation by premature polyadenylation attenuates human
mobile element activity. Nat. Genet. 35, 363–366
47. Wheelan, S.J. et al. (2005) Gene-breaking: a new paradigm for
human retrotransposon-mediated gene evolution. Genome
Res. 15, 1073–1078
48. Faulkner, G.J. et al. (2009) The regulated retrotransposon
transcriptome of mammalian cells. Nat. Genet. 41, 563–571
49. Macia, A. et al. (2011) Epigenetic control of retrotransposon
expression in human embryonic stem cells. Mol. Cell. Biol. 31,
300–316
50. Philippe, C. et al. (2016) Activation of individual L1 retrotrans-
poson instances is restricted to cell-type dependent permissive
loci. Elife 5, e13926
51. Speek, M. (2001) Antisense promoter of human L1 retrotrans-
poson drives transcription of adjacent cellular genes. Mol. Cell.
Biol. 21, 1973–1985
52. Ewing, A.D. and Kazazian, H.H., Jr (2011) Whole-genome
resequencing allows detection of many rare LINE-1 insertion
alleles in humans. Genome Res. 21, 985–990
53. Coufal, N.G. et al. (2009) L1 retrotransposition in human neural
progenitor cells. Nature 460, 1127–1131
54. Hata, K. and Sakaki, Y. (1997) Identiﬁcation of critical CpG sites
for repression of L1 transcription by DNA methylation. Gene
189, 227–234
55. Muotri, A.R. et al. (2010) L1 retrotransposition in neurons is
modulated by MeCP2. Nature 468, 443–446
56. Muotri, A.R. et al. (2005) Somatic mosaicism in neuronal
precursor cells mediated by L1 retrotransposition. Nature 435,
903–910
57. Jacobs, F.M. et al. (2014) An evolutionary arms race between
KRAB zinc-ﬁnger genes ZNF91/93 and SVA/L1 retrotranspo-
sons. Nature 516, 242–245
58. Imbeault, M. et al. (2017) KRAB zinc-ﬁnger proteins contribute
to the evolution of gene regulatory networks. Nature 543,
550–554
59. Friedli, M. and Trono, D. (2015) The developmental control of
transposable elements and the evolution of higher species.
Annu. Rev. Cell Dev. Biol. 31, 429–451
60. Gerdes, P. et al. (2016) Transposable elements in the mamma-
lian embryo: pioneers surviving through stealth and service.
Genome Biol. 17, 100
61. Goodier, J.L. (2016) Restricting retrotransposons: a review.
Mob DNA 7, 16
62. Thompson, P.J. et al. (2016) Long terminal repeats: from
parasitic elements to building blocks of the transcriptional reg-
ulatory repertoire. Mol. Cell 62, 766–776
63. Heidmann, T. et al. (1988) An indicator gene to demonstrate
intracellular transposition of defective retroviruses. Proc. Natl.
Acad. Sci. U. S. A. 85, 2219–2223
64. Freeman, J.D. et al. (1994) A modiﬁed indicator gene for
selection of retrotransposition events in mammalian cells.
Biotechniques 17, 46, 48–49, 52
65. Ostertag, E.M. et al. (2000) Determination of L1 retrotranspo-
sition kinetics in cultured cells. Nucleic Acids Res. 28,
1418–1423Trends in Genetics, Month Year, Vol. xx, No. yy 13
TIGS 1381 No. of Pages 1566. Ostertag, E.M. et al. (2002) A mouse model of human L1
retrotransposition. Nat. Genet. 32, 655–660
67. Xie, Y. et al. (2011) Characterization of L1 retrotransposition with
high-throughput dual-luciferase assays. Nucleic Acids Res. 39,
e16
68. Rangwala, S.H. and Kazazian, H.H., Jr (2009) The L1
retrotransposition assay: a retrospective and toolkit. Methods
49, 219–226
69. Iskow, R.C. et al. (2010) Natural mutagenesis of human
genomes by endogenous retrotransposons. Cell 141,
1253–1261
70. McConnell, M.J. et al. (2017) Intersection of diverse neuronal
genomes and neuropsychiatric disease: the Brain Somatic
Mosaicism Network. Science 356
71. Mir, A.A. et al. (2015) euL1db: the European database of L1HS
retrotransposon insertions in humans. Nucleic Acids Res. 43,
D43–47
72. Sudmant, P.H. et al. (2015) An integrated map of structural
variation in 2,504 human genomes. Nature 526, 75–81
73. Wang, J. et al. (2006) dbRIP: a highly integrated database of
retrotransposon insertion polymorphisms in humans. Hum.
Mutat. 27, 323–329
74. Helman, E. et al. (2014) Somatic retrotransposition in human
cancer revealed by whole-genome and exome sequencing.
Genome Res. 24, 1053–1063
75. Lee, E. et al. (2012) Landscape of somatic retrotransposition in
human cancers. Science 337, 967–971
76. Tubio, J.M. et al. (2014) Extensive transduction of nonrepetitive
DNA mediated by L1 retrotransposition in cancer genomes.
Science 345, 1251343
77. Ostertag, E.M. and Kazazian, H.H. (2001) Twin priming: a
proposed mechanism for the creation of inversions in L1 retro-
transposition. Genome Res. 11, 2059–2065
78. Badge, R.M. et al. (2003) ATLAS: a system to selectively identify
human-speciﬁc L1 insertions. Am. J. Hum. Genet. 72, 823–838
79. Rodic, N. et al. (2015) Retrotransposon insertions in the clonal
evolution of pancreatic ductal adenocarcinoma. Nat. Med. 21,
1060–1064
80. Baillie, J.K. et al. (2011) Somatic retrotransposition alters the
genetic landscape of the human brain. Nature 479, 534–537
81. Upton, K.R. et al. (2015) Ubiquitous L1 mosaicism in hippocam-
pal neurons. Cell 161, 228–239
82. Evrony, G.D. et al. (2012) Single-neuron sequencing analysis of
L1 retrotransposition and somatic mutation in the human brain.
Cell 151, 483–496
83. Evrony, G.D. et al. (2015) Cell lineage analysis in human brain
using endogenous retroelements. Neuron 85, 49–59
84. Garcia-Perez, J.L. et al. (2010) Epigenetic silencing of
engineered L1 retrotransposition events in human embryonic
carcinoma cells. Nature 466, 769–773
85. Prak, E.T. et al. (2003) Tracking an embryonic L1 retrotranspo-
sition event. Proc. Natl. Acad. Sci. U. S. A. 100, 1832–1837
86. Garcia-Perez, J.L. et al. (2007) LINE-1 retrotransposition in
human embryonic stem cells. Hum. Mol. Genet. 16, 1569–1577
87. Klawitter, S. et al. (2016) Reprogramming triggers endogenous
L1 and Alu retrotransposition in human induced pluripotent stem
cells. Nat. Commun. 7, 10286
88. Branciforte, D. and Martin, S.L. (1994) Developmental and cell
type speciﬁcity of LINE-1 expression in mouse testis: implica-
tions for transposition. Mol. Cell. Biol. 14, 2584–2592
89. Malki, S. et al. (2014) A role for retrotransposon LINE-1 in fetal
oocyte attrition in mice. Dev. Cell 29, 521–533
90. Packer, A.I. et al. (1993) A discrete LINE-1 transcript in mouse
blastocysts. Dev. Biol. 157, 281–283
91. Trelogan, S.A. and Martin, S.L. (1995) Tightly regulated,
developmentally speciﬁc expression of the ﬁrst open reading
frame from LINE-1 during mouse embryogenesis. Proc. Natl.
Acad. Sci. U. S. A. 92, 1520–1524
92. Kano, H. et al. (2009) L1 retrotransposition occurs mainly in
embryogenesis and creates somatic mosaicism. Genes Dev.
23, 1303–131214 Trends in Genetics, Month Year, Vol. xx, No. yy93. An, W. et al. (2006) Active retrotransposition by a synthetic L1
element inmice.Proc.Natl. Acad.Sci.U.S.A.103,18662–18667
94. Newkirk, S.J. et al. (2017) Intact piRNA pathway prevents L1
mobilization in male meiosis. Proc. Natl. Acad. Sci. U. S. A. 114,
E5635–5644
95. Freeman, P. et al. (2011) L1 hybridization enrichment: a method
for directly accessing de novo L1 insertions in the human
germline. Hum. Mutat. 32, 978–988
96. Brouha, B. et al. (2002) Evidence consistent with human L1
retrotransposition in maternal meiosis I. Am. J. Hum. Genet. 71,
327–336
97. van den Hurk, J.A. et al. (2007) L1 retrotransposition can occur
early in human embryonic development. Hum. Mol. Genet. 16,
1587–1592
98. Castro-Diaz, N. et al. (2014) Evolutionally dynamic L1 regulation
in embryonic stem cells. Genes. Dev. 28, 1397–1409
99. Macia, A. et al. (2017) Engineered LINE-1 retrotransposition in
nondividing human neurons. Genome Res. 27, 335–348
100. Wissing, S. et al. (2012) Reprogramming somatic cells into iPS
cells activates LINE-1 retroelement mobility. Hum. Mol. Genet.
21, 208–218
101. Friedli, M. et al. (2014) Loss of transcriptional control over
endogenous retroelements during reprogramming to pluripo-
tency. Genome Res. 24, 1251–1259
102. Walter, M. et al. (2016) An epigenetic switch ensures transposon
repression upon dynamic loss of DNA methylation in embryonic
stem cells. Elife 5, e11418
103. Arokium, H. et al. (2014) Deep sequencing reveals low incidence
of endogenous LINE-1 retrotransposition in human induced
pluripotent stem cells. PLoS One 9, e108682
104. Lister, R. et al. (2011) Hotspots of aberrant epigenomic reprog-
ramming in human induced pluripotent stem cells. Nature 471,
68–73
105. Bhutani, K. et al. (2016) Whole-genome mutational burden
analysis of three pluripotency induction methods. Nat.
Commun. 7, 10536
106. Gore, A. et al. (2011) Somatic coding mutations in human
induced pluripotent stem cells. Nature 471, 63–67
107. Hussein, S.M. et al. (2011) Copy number variation and selection
during reprogramming to pluripotency. Nature 471, 58–62
108. Quinlan, A.R. et al. (2011) Genome sequencing of mouse
induced pluripotent stem cells reveals retroelement stability
and infrequent DNA rearrangement during reprogramming. Cell
Stem Cell 9, 366–373
109. Goodier, J.L. et al. (2007) LINE-1 ORF1 protein localizes in
stress granules with other RNA-binding proteins, including
components of RNA interference RNA-induced silencing
complex. Mol. Cell. Biol. 27, 6469–6483
110. Han, J.S. and Boeke, J.D. (2004) A highly active synthetic
mammalian retrotransposon. Nature 429, 314–318
111. Naas, T.P. et al. (1998) An actively retrotransposing, novel
subfamily of mouse L1 elements. EMBO J. 17, 590–597
112. Theunissen, T.W. et al. (2016) Molecular Criteria for Deﬁning the
Naive Human Pluripotent State. Cell Stem Cell 19, 502–515
113. Grandi, F.C. et al. (2013) LINE-1-derived poly(A) microsatellites
undergo rapid shortening and create somatic and germline
mosaicism in mice. Mol. Biol. Evol. 30, 503–512
114. Howell, R. and Usdin, K. (1997) The ability to form intrastrand
tetraplexes is an evolutionarily conserved feature of the 30 end of
L1 retrotransposons. Mol. Biol. Evol. 14, 144–155
115. Sahakyan, A.B. et al. (2017) G-quadruplex structures within the
30 UTR of LINE-1 elements stimulate retrotransposition. Nat.
Struct. Mol. Biol. 24, 243–247
116. Hazen, J.L. et al. (2016) The complete genome sequences,
unique mutational spectra, and developmental potency of adult
neurons revealed by cloning. Neuron 89, 1223–1236
117. Babushok, D.V. et al. (2006) L1 integration in a transgenic
mouse model. Genome Res. 16, 240–250
118. Kubo, S. et al. (2006) L1 retrotransposition in nondividing and
primary human somatic cells.Proc. Natl. Acad. Sci. U. S. A. 103,
8036–8041
TIGS 1381 No. of Pages 15119. Lodato, M.A. et al. (2015) Somatic mutation in single human
neurons tracks developmental and transcriptional history.
Science 350, 94–98
120. Chen, C. et al. (2017) Single-cell whole-genome analyses by
linear ampliﬁcation via transposon insertion (LIANTI). Science
356, 189–194
121. Evrony, G.D. et al. (2016) Resolving rates of mutation in the brain
using single-neuron genomics. Elife 5, e12966
122. Quail, M.A. et al. (2012) A tale of three next generation sequenc-
ing platforms: comparison of Ion Torrent, Paciﬁc Biosciences
and Illumina MiSeq sequencers. BMC Genomics 13, 341
123. De Cecco, M. et al. (2013) Genomes of replicatively senescent
cells undergo global epigenetic changes leading to gene
silencing and activation of transposable elements. Aging Cell 12,
247–256
124. Krug, L. et al. (2017) Retrotransposon activation contributes to
neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS
Genet. 13, e1006635
125. Li, W. et al. (2013) Activation of transposable elements during
aging and neuronal decline in Drosophila. Nat. Neurosci. 16,
529–531
126. Van Meter, M. et al. (2014) SIRT6 represses LINE1 retrotrans-
posons by ribosylating KAP1 but this repression fails with stress
and age. Nat. Commun. 5, 5011
127. Kobayashi, K. et al. (2016) Single-cell memory regulates a neural
circuit for sensory behavior. Cell Rep. 14, 11–21
128. Muotri, A.R. et al. (2009) Environmental inﬂuence on L1 retro-
transposons in the adult hippocampus. Hippocampus 19,
1002–1007
129. Singer, T. et al. (2010) LINE-1 retrotransposons: mediators of
somatic variation in neuronal genomes? Trends Neurosci. 33,
345–354
130. Yu, F. et al. (2001) Methyl-CpG-binding protein 2 represses
LINE-1 expression and retrotransposition but not Alu transcrip-
tion. Nucleic Acids Res. 29, 4493–4501
131. Bundo, M. et al. (2014) Increased L1 retrotransposition in the
neuronal genome in schizophrenia. Neuron 81, 306–313
132. Coufal, N.G. et al. (2011) Ataxia telangiectasia mutated (ATM)
modulates long interspersed element-1 (L1) retrotransposition in
human neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 108,
20382–20387
133. Guy, J. et al. (2007) Reversal of neurological defects in a mouse
model of Rett syndrome. Science 315, 1143–1147
134. Macfarlane, C.M. et al. (2013) Transduction-speciﬁc ATLAS
reveals a cohort of highly active L1 retrotransposons in human
populations. Hum. Mutat. 34, 974–985135. Farley, A.H. et al. (2004) More active human L1 retrotranspo-
sons produce longer insertions.Nucleic Acids Res. 32, 502–510
136. Herculano-Houzel, S. and Lent, R. (2005) Isotropic fractionator:
a simple, rapid method for the quantiﬁcation of total cell and
neuron numbers in the brain. J. Neurosci. 25, 2518–2521
137. Eickbush, M.T. and Eickbush, T.H. (2011) Retrotransposition of
R2 elements in somatic nuclei during the early development of
Drosophila. Mob DNA 2, 11
138. Perrat, P.N. et al. (2013) Transposition-driven genomic
heterogeneity in the Drosophila brain. Science 340, 91–95
139. Boeke, J.D. (2003) The unusual phylogenetic distribution of
retrotransposons: a hypothesis. Genome Res. 13, 1975–1983
140. Gilbert, N. et al. (2005) Multiple fates of L1 retrotransposition
intermediates in cultured human cells. Mol. Cell. Biol. 25,
7780–7795
141. Morrish, T.A. et al. (2002) DNA repair mediated by endonucle-
ase-independent LINE-1 retrotransposition. Nat. Genet. 31,
159–165
142. Gilbert, N. et al. (2002) Genomic deletions created upon LINE-1
retrotransposition. Cell 110, 315–325
143. Garcia-Perez, J.L. et al. (2007) Distinct mechanisms for trans-
mediated mobilization of cellular RNAs by the LINE-1 reverse
transcriptase. Genome Res. 17, 602–611
144. Kajikawa, M. and Okada, N. (2002) LINEs mobilize SINEs in the
eel through a shared 3’ sequence. Cell 111, 433–444
145. Sugano, T. et al. (2006) Isolation and characterization of
retrotransposition-competent LINEs from zebraﬁsh. Gene 365,
74–82
146. Graham, V. et al. (2003) SOX2 functions to maintain neural
progenitor identity. Neuron 39, 749–765
147. Tchenio, T. et al. (2000) Members of the SRY family regulate
the human LINE retrotransposons. Nucleic Acids Res. 28,
411–415
148. Swergold, G.D. (1990) Identiﬁcation, characterization, and cell
speciﬁcity of a human LINE-1 promoter. Mol. Cell. Biol. 10,
6718–6729
149. Athanikar, J.N. et al. (2004) A YY1-binding site is required for
accurate human LINE-1 transcription initiation. Nucleic Acids
Res. 32, 3846–3855
150. Yang, N. et al. (2003) An important role for RUNX3 in human L1
transcription and retrotransposition. Nucleic Acids Res. 31,
4929–4940Trends in Genetics, Month Year, Vol. xx, No. yy 15
